By Daniel Trotta
HAVANA (Reuters) – – A research center for cancer and a software company in the United States arrived on Tuesday cooperation agreements with counterparts in Cuba, as part of a business mission that visited for two days the island, which was headed by the governor of New York, Andrew Cuomo.
Cuomo, a Democrat politician, is the first governor to visit the Caribbean island since the presidents United States, Barack Obama, and Cuba, Raul Castro, announced in December the start of a process to restore diplomatic relations and normalizing trade and travel.
The Molecular Immunology Center of Cuba and Roswell Park Institute in Buffalo, in the state of New York, signed an agreement to develop clinical trials of a vaccine against lung cancer in the United States, said the president of the American Institute, Candace Johnson.
The company Infor New York [INFGS.UL] identified a Cuban partner and reached an agreement to distribute software in Cuba, said its chief executive, Charles Phillips.
“We were surprised and impressed the level technology and experience they have in health technology, “Phillips told reporters before returning to the United States after being part of a delegation of businessmen from New York who visited the island.
Both agreements were announced at the Havana airport, following a two-day visit to Cuba of the delegation of 18 business leaders and academics, led by Cuomo.
Obama has eased some restrictions on economic embargo Washington applies to Havana, but would need Congress controlled by Republicans, to lift the sanctions altogether and establish a normal trade.
Among the executives traveled with Cuomo were senior JetBlue Airways Corp. Pfizer Inc. and MasterCard Inc.
Cuomo said the purpose of the delegation is to assist companies in New York to become “the first to go” to do business after the thaw in relations between United States and Cuba.
The Roswell Institute said he could close the deal as a result of the trade mission, said Johnson.
“This agreement provides for cooperation between our two institutions to develop A vaccine against lung cancer, “he said, referring to the vaccine developed by scientists at the Center for Molecular Immunology, Cuba.
” We are very excited to bring this to the US to treat patients ” he said.
Phillips, meanwhile, did not reveal the name of their Cuban partners, but said the agreement was reached Monday night during a Cuban dinner that included rice and beans.
However, shortly after Infor spokesman Dan Barnhardt, said in an email that Infor reached a preliminary agreement with DESOFT leading information technology in Cuba, which has about 2,500 employees.
Infor also closed agreements with other Cuban leader, Softel, and the University of Information Science.
The partnership will initially focus on the integration of health data, a specialty Infor, which automates 72 percent of US hospitals with over 150 beds, the spokesman said.
(Reporting by Daniel Trotta. Translation into Spanish in Havana Nelson Acosta Editing .; Spanish by Silene Ramirez NAB SR JLL REUTERS /)
No comments:
Post a Comment